Sensorion   Report issue

For profit Phase 1 Phase 3
Founded: Clapier France (2009)

Organization Overview

First Clinical Trial
2016
NCT02772796
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Sensorion | Sensorion SA